blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3930689

EP3930689 - PHARMACEUTICAL COMPOSITIONS FOR USE IN TREATING PAIN [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  09.02.2024
Database last updated on 14.09.2024
FormerRequest for examination was made
Status updated on  03.12.2021
FormerThe international publication has been made
Status updated on  04.09.2020
Formerunknown
Status updated on  06.04.2020
Most recent event   Tooltip30.04.2024New entry: Reply to examination report 
Applicant(s)For all designated states
TLC Biopharmaceuticals, Inc.
611 Gateway Blvd., Suite 830
South San Francisco CA 94080 / US
For all designated states
Taiwan Liposome Company, Ltd.
11F-1 No 3 Yuanqu Street
Nangang District
Taipei City 11503 / TW
[2022/01]
Inventor(s)01 / TAI, Tien-Tzu
11F-1, No. 3, Yuanqu Street, Nangang District
Taipei City 11503 / TW
02 / TSENG, Yun-Long
11F-1, No. 3, Yuanqu Street, Nangang District
Taipei City 11503 / TW
03 / SHIH, Sheue-Fang
11F-1, No. 3, Yuanqu Street, Nangang District
Taipei City 11503 / TW
04 / KUO, Min-Wen
11F-1, No. 3, Yuanqu Street, Nangang District
Taipei City 11503 / TW
05 / BROWN, Carl, Oscar
11F-1, No. 3, Yuanqu Street, Nangang District
Taipei City 11503 / TW
06 / WANG, Hui-Ting
11F-1, No. 3, Yuanqu Street, Nangang District
Taipei City 11503 / TW
07 / JAO, Weenee, Yeun Ng
11F-1, No. 3, Yuanqu Street, Nangang District
Taipei City 11503 / TW
08 / HU, Pei-Hsien
11F-1, No. 3, Yuanqu Street, Nangang District
Taipei City 11503 / TW
09 / YU, Wan-Ni
11F-1, No. 3, Yuanqu Street, Nangang District
Taipei City 11503 / TW
10 / HONG, Keelung
611 Gateway Blvd., Suite 830 South
San Francisco, CA 94080 / US
11 / KAO, Hao-Wen
611 Gateway Blvd., Suite 830 South
San Francisco, CA 94080 / US
12 / LIN, Yi-Yu
611 Gateway Blvd., Suite 830 South
San Francisco, CA 94080 / US
[N/P]
Former [2022/01]01 / TAI, Tien-Tzu
Taipei City 11503 / TW
02 / TSENG, Yun-Long
Taipei City 11503 / TW
03 / SHIH, Sheue-Fang
Taipei City 11503 / TW
04 / KUO, Min-Wen
Taipei City 11503 / TW
05 / BROWN, Carl, Oscar
Taipei City 11503 / TW
06 / WANG, Hui-Ting
Taipei City 11503 / TW
07 / JAO, Weenee, Yeun Ng
Taipei City 11503 / TW
08 / HU, Pei-Hsien
Taipei City 11503 / TW
09 / YU, Wan-Ni
Taipei City 11503 / TW
10 / HONG, Keelung
San Francisco, CA 94080 / US
11 / KAO, Hao-Wen
San Francisco, CA 94080 / US
12 / LIN, Yi-Yu
San Francisco, CA 94080 / US
Representative(s)Zimmermann & Partner Patentanwälte mbB
Postfach 330 920
80069 München / DE
[2022/01]
Application number, filing date20714390.026.02.2020
[2022/01]
WO2020US19806
Priority number, dateUS201962810378P26.02.2019         Original published format: US 201962810378 P
US201962848286P15.05.2019         Original published format: US 201962848286 P
[2022/01]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020176568
Date:03.09.2020
Language:EN
[2020/36]
Type: A1 Application with search report 
No.:EP3930689
Date:05.01.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 03.09.2020 takes the place of the publication of the European patent application.
[2022/01]
Search report(s)International search report - published on:EP03.09.2020
ClassificationIPC:A61K9/14, A61K9/19, A61K31/445, A61P23/02, A61K9/127
[2022/01]
CPC:
A61K9/19 (EP,KR); A61K31/167 (EP,KR,US); A61K31/445 (EP,KR);
A61K47/24 (KR,US); A61K47/28 (KR); A61K9/127 (EP,US);
A61K9/145 (EP,KR); A61P23/02 (EP,KR,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/01]
TitleGerman:PHARMAZEUTISCHE ZUSAMMENSETZUNGEN ZUR SCHMERZBEHANDLUNG[2022/01]
English:PHARMACEUTICAL COMPOSITIONS FOR USE IN TREATING PAIN[2022/01]
French:COMPOSITIONS PHARMACEUTIQUES POUR UTILISATION DANS LE TRAITEMENT DE LA DOULEUR[2022/01]
Entry into regional phase26.08.2021National basic fee paid 
26.08.2021Designation fee(s) paid 
26.08.2021Examination fee paid 
Examination procedure26.08.2021Examination requested  [2022/01]
26.08.2021Date on which the examining division has become responsible
09.03.2022Amendment by applicant (claims and/or description)
13.02.2024Despatch of a communication from the examining division (Time limit: M04)
30.04.2024Reply to a communication from the examining division
Fees paidRenewal fee
17.02.2022Renewal fee patent year 03
09.02.2023Renewal fee patent year 04
08.02.2024Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]WO9949849  (YISSUM RES DEV CO [IL], et al) [Y] 14 * page 3, line 12 - page 6, line 20 * * table 1 *;
 [XYI]US2015250724  (YAMASHITA KEIKO [JP], et al) [X] 1-3,6,7,9,11-13,15-20,23,30-34 * page 2, paragraphs 0020-0033 * * page 3, paragraph 0039 - page 4, paragraph 0057 * * page 15, paragraphs 0202-0209 * * example - * [Y] 5,14,24-26,35 [I] 4,10,21,22;
 [Y]CN108379269  (WUHAN BAINALIKANG BIOLOGICAL PHARMACEUTICAL CO LTD) [Y] 5,24-26,35 * paragraphs [0001] - [0006] * * example - *;
 [XI]  - Anonymous, "EXPAREL (bupivacaine liposome injectable suspension)", (201804), pages 1 - 28, URL: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022496s9lbl.pdf, (20200515), XP055696012 [X] 1-3,6-9,11-13,17-20,23,27-34,36 * paragraph [0011] * * paragraph [0014] * [I] 10,16,21,22
 [T]  - "A Basic Guide to Particle Characterization", Malvern Instruments Worldwide - White Paper, (20120502), pages 1 - 26, URL: http://golik.co.il/Data/ABasicGuidtoParticleCharacterization(2)_1962085150.pdf, XP055089322 [T] 18,20
by applicant   - Regional Anesthesia and Pain Medicine, (19980000), vol. 23, no. 2, pages 189 - 196
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.